Skip to content
TrialScanner

NCT04131309

A Study of Daratumumab Monotherapy in Previously Untreated Patients With Stage 3B Light Chain (AL) Amyloidosis

Phase 2CompletedJNJCollaborator

Registry record

Lead sponsor
Stichting European Myeloma Network
Conditions
Light Chain (AL) Amyloidosis, Stage 3B
Primary completion
Jan 27, 2025Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT04131309 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

1 change recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT04131309: A Study of Daratumumab... | TrialScanner